85 related articles for article (PubMed ID: 11778280)
1. [Preliminary clinical comparison of HLF and ELF regimen in the treatment of advanced gastric carcinoma in middle-aged and elderly patients].
Xiong X; Zhu Z; Wen Z
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):411-3. PubMed ID: 11778280
[TBL] [Abstract][Full Text] [Related]
2. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
3. Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.
Van Cutsem E; Filez L; Dewyspelaere J; Penninckx F; Janssens J
Anticancer Res; 1995; 15(3):1079-80. PubMed ID: 7645929
[TBL] [Abstract][Full Text] [Related]
4. Etoposide, leucovorin, 5-fluorouracil (ELF) combination chemotherapy for advanced gastric cancer: experience with two treatment schedules incorporating intravenous or oral etoposide.
Taal BG; Teller FG; ten Bokkel Huinink WW; Boot H; Beijnen JH; Dubbelman R
Ann Oncol; 1994 Jan; 5(1):90-2. PubMed ID: 8172800
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced gastric cancer with a modified regimen of etoposide/leucovorin/5-fluorouracil.
Chiou TJ; Kung SP; Hsieh RK; Fan S; Tzeng CH; Wei CH; Chen PM
Cancer Invest; 1996; 14(3):197-201. PubMed ID: 8630679
[TBL] [Abstract][Full Text] [Related]
6. Etoposide, l-leucovorin and fluorouracil (ELF) regimen in metastatic gastric cancer: a phase II study.
Adamo V; Scimone A; Maisano R; Altavilla G; Ferraro G; Laudani A; Pergolizzi S; Zanghì M
J Chemother; 1999 Feb; 11(1):74-7. PubMed ID: 10078785
[TBL] [Abstract][Full Text] [Related]
7. [The evaluation of LFH or LFPH in the treatment of advanced cancer of gastric cardia and colorectal cancer].
Zhang XD; Shen L; Li Y; Li J; Yang BQ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):289-91. PubMed ID: 12839698
[TBL] [Abstract][Full Text] [Related]
8. [Clinical results of advanced gastric cancer patients treated with oxaliplatin-containing regimen].
Zhang WM; Xu GH; Ju AP; Zheng YT; Jiang Q
Ai Zheng; 2003 Dec; 22(12):1346-8. PubMed ID: 14693066
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in gastric cancer: an economic evaluation of the FAM (5-fluorouracil, adriamycin, mitomycin C) versus ELF (etoposide, leucovorin, 5-fluorouracil) regimens.
Norum J; Angelsen V
J Chemother; 1995 Oct; 7(5):455-9. PubMed ID: 8596132
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer.
Rosati G; Cordio S; Caputo G; Condorelli S; Germano D; Mattina M; Amadio P; Reggiardo G; Manzione L
J Chemother; 2007 Oct; 19(5):570-6. PubMed ID: 18073157
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen.
Raderer M; Kornek GV; Hejna MH; Miholic J; Weinlaender G; Brodowicz T; Fiebiger WC; Valencak JB; Scheithauer W
Eur J Cancer; 1998 Jun; 34(7):1128-30. PubMed ID: 9849466
[TBL] [Abstract][Full Text] [Related]
12. Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group.
Vanhoefer U; Rougier P; Wilke H; Ducreux MP; Lacave AJ; Van Cutsem E; Planker M; Santos JG; Piedbois P; Paillot B; Bodenstein H; Schmoll HJ; Bleiberg H; Nordlinger B; Couvreur ML; Baron B; Wils JA
J Clin Oncol; 2000 Jul; 18(14):2648-57. PubMed ID: 10894863
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy.
di Bartolomeo M; Bajetta E; de Braud F; Bochicchio AM; Gebbia V; Bozzetti F; Doci R; Bonfanti G; Cozzaglio L
Oncology; 1995; 52(1):41-4. PubMed ID: 7800341
[TBL] [Abstract][Full Text] [Related]
14. High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer--a phase II study in elderly patients or patients with cardiac risk.
Wilke H; Preusser P; Fink U; Achterrath W; Lenaz L; Stahl M; Schober C; Link H; Meyer HJ; Lucke B
Invest New Drugs; 1990 Feb; 8(1):65-70. PubMed ID: 2345071
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of oxaliplatin plus 5-fluorouracil/leucovorin calcium combined with concurrent radiotherapy for local advanced gastric cancer].
Shao ZY; Zhang JD
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2547-9. PubMed ID: 19080647
[TBL] [Abstract][Full Text] [Related]
16. [Oxaliplatin combined with ELF regimen in the treatment of patients with advanced gastric cancer].
Lou F; Zhu YH; Pan HM
Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):75-8. PubMed ID: 19538878
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancer.
Kim BG; Oh SY; Kwon HC; Lee S; Lee DM; Kim SG; Kim DK; Jang JS; Kim MC; Kim SH; Kim HJ
Am J Clin Oncol; 2010 Jun; 33(3):246-50. PubMed ID: 19770628
[TBL] [Abstract][Full Text] [Related]
18. A phase II trial of etoposide, leucovorin and 5-fluorouracil (ELF) in patients with advanced gastric cancer.
Au E; Koo WH; Tan EH; Ang PT
J Chemother; 1996 Aug; 8(4):300-3. PubMed ID: 8873837
[TBL] [Abstract][Full Text] [Related]
19. New developments in the treatment of gastric carcinoma.
Wilke H; Preusser P; Fink U; Achterrath W; Meyer HJ; Stahl M; Lenaz L; Meyer J; Siewert JR; Geerlings H
Semin Oncol; 1990 Feb; 17(1 Suppl 2):61-70. PubMed ID: 2305269
[TBL] [Abstract][Full Text] [Related]
20. [Biweekly regimen of high dose of leucovorin, 5-fluorouracil, and paclitaxel for patients with advanced gastric cancer].
Feng JF; Lu JW; Sun XF
Ai Zheng; 2004 Dec; 23(12):1704-6. PubMed ID: 15601565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]